worldwid
peopl
bronchiectasi
unrel
cystic
fibrosi
cf
cf
although
regard
affluent
countri
orphan
diseas
bronchiectasi
remain
major
contributor
chronic
respiratori
morbid
affluent
less
affluent
countri
increas
appreci
bronchiectasi
adult
renew
interest
bronchiectasi
result
greater
research
depth
albeit
still
proportion
littl
research
children
inde
bronchiectasi
regard
european
respiratori
societi
one
neglect
diseas
respiratori
medicin
chapter
address
childhood
bronchiectasi
chronic
suppur
lung
diseas
csld
protract
bacteri
bronchiti
pbb
unrel
cf
underli
pulmonari
host
defens
defici
ciliari
dyskinesia
syndrom
immunodefici
cover
elsewher
textbook
bronchiectasi
csld
pbb
share
common
featur
differ
diagnost
entiti
overlap
fig
bronchiectasi
patholog
state
conduct
airway
manifest
radiograph
evid
bronchial
dilat
clinic
chronic
product
cough
bronchiectasi
focal
recurr
wet
product
cough
infecti
exacerb
diffus
result
gener
airway
obstruct
destruct
eventu
respiratori
failur
diagnost
criteria
bronchiectasi
base
radiograph
featur
chest
highresolut
computer
tomographi
chrct
although
sensit
adultdefin
radiograph
criteria
question
appli
children
bronchiectasi
may
also
occur
patient
interstiti
lung
diseas
traction
airway
caus
secondari
bronchial
dilat
traction
bronchiectasi
absenc
wet
product
cough
consid
csld
describ
clinic
syndrom
symptom
chronic
endobronchi
suppur
exist
without
chrct
evid
bronchiectasi
present
symptom
ident
bronchiectasi
includ
prolong
moist
product
cough
respons
antibiot
without
exert
dyspnea
increas
airway
reactiv
recurr
chest
infect
absenc
physic
sign
pose
safeti
concern
regard
cancer
risk
radiat
children
adolesc
young
adult
time
chrct
scan
diagnos
bronchiectasi
import
scan
perform
differ
clinic
state
acut
pulmonari
exacerb
immedi
follow
treatment
clinic
stabl
may
yield
differ
result
chrct
scan
ideal
perform
nonacut
state
state
may
differ
posttreat
state
bronchial
dilat
resolv
complet
children
radiolog
defin
bronchiectasi
chrct
scan
repeat
immedi
follow
intens
medic
therapi
thu
recommend
hrct
scan
best
perform
nonacut
state
bronchiectasi
diagnos
symptom
csld
present
hrct
find
meet
pediatr
rather
adult
radiolog
criteria
pbb
condit
like
prebronchiectasi
state
first
describ
diagnost
entiti
clear
clinic
criteria
support
laboratori
studi
although
astut
clinician
long
recogn
pbblike
condit
pbb
discuss
later
chapter
separ
entiti
affluent
countri
preval
childhood
bronchiectasi
substanti
declin
sinc
field
report
children
bronchiectasi
period
note
declin
incid
case
per
peopl
english
studi
found
children
refer
respiratori
specialti
servic
bronchiectasi
reduc
incid
time
ascrib
reduc
crowd
improv
immun
program
better
hygien
nutrit
earli
access
medic
care
howev
bronchiectasi
increasingli
recogn
worldwid
import
contributor
chronic
respiratori
morbid
less
affluent
countri
indigen
nonindigen
popul
affluent
countri
inde
bronchiectasi
rare
affluent
countri
common
among
certain
group
exampl
alaskan
yupik
children
unit
state
aborigin
australia
maori
pacif
island
new
zealand
among
popul
preval
childhood
bronchiectasi
per
children
canadian
studi
conserv
estim
preval
bronchiectasi
among
inuit
children
live
nunavut
per
avail
nation
incid
data
children
new
zealand
rate
per
year
old
children
per
year
almost
twice
cf
northern
territori
australia
high
proport
indigen
peopl
incid
first
year
life
per
adult
estim
preval
rate
increas
annual
chang
base
sampl
outpati
medicar
claim
unit
state
unit
kingdom
uk
preval
bronchiectasi
peopl
age
year
increas
confid
interv
ci
per
per
estim
far
exceed
preval
cf
given
need
ct
scan
diagnos
bronchiectasi
preval
incid
data
would
underestim
furthermor
recognit
bronchiectasi
physician
depend
surpris
mani
case
children
adult
misdiagnos
difficult
asthma
chronic
obstruct
pulmonari
diseas
copd
proport
adult
copd
underli
bronchiectasi
importantli
major
bronchiectasi
adulthood
root
childhood
one
studi
adult
bronchiectasi
found
patient
chronic
respiratori
symptom
childhood
hospit
rate
adult
noncf
bronchiectasi
unit
state
also
increas
last
two
decad
ageadjust
rate
increas
significantli
averag
annual
percent
increas
among
men
among
women
german
hospit
statist
also
increas
period
annual
ageadjust
rate
bronchiectasi
hospit
per
popul
likewis
australian
state
queensland
document
increas
hospit
per
popul
data
less
affluent
countri
suggest
bronchiectasi
still
associ
poor
outcom
exampl
respiratori
failur
tunisian
followup
studi
mortal
pediatr
bronchiectasi
rare
report
arguabl
child
without
seriou
comorbid
die
bronchiectasi
howev
england
wale
studi
report
death
year
age
group
children
sd
year
depress
trait
anxieti
score
elev
bronchiectasi
childrat
physic
health
qol
score
significantli
lower
bronchiectasi
compar
control
determin
qol
relat
age
forc
expiratori
volum
one
second
fev
forc
vital
capac
fvc
predict
dyspnea
sever
differ
australian
turkish
studi
like
relat
differ
qol
scale
use
sever
diseas
like
qol
score
correl
diseas
sever
sever
diseas
similar
relationship
spirometri
radiolog
extent
bronchiectasi
spirometri
often
normal
mild
local
diseas
signific
correl
spirometri
indic
radiolog
score
seen
sever
diseas
nevertheless
studi
show
neg
impact
bronchiectasi
children
andor
parent
qol
mental
health
poor
sleep
qualiti
also
report
bronchiectasi
result
varieti
airway
insult
predispos
condit
ultim
injur
airway
lead
recurr
persist
airway
infect
destruct
exampl
condit
list
tabl
bronchiectasi
develop
individu
structur
airway
abnorm
bronchomalacia
endobronchi
tuberculosi
central
airway
compress
retain
aspir
foreign
bodi
impair
mucu
bacteri
clearanc
howev
current
evid
airway
malacia
caus
bronchiectasi
human
studi
persist
airway
injuri
narrow
associ
bronchiol
obliteran
bo
due
viral
injuri
follow
lung
transplant
lead
bronchiectasi
recurr
airway
injuri
occur
aspir
syndrom
also
result
bronchiectasi
select
pediatr
cohort
variou
set
countri
describ
frequenc
associ
condit
summar
tabl
impair
upper
airway
defens
may
also
predispos
bronchiectasi
base
common
associ
rhinosinus
bronchitisbronchiectasi
inde
sinus
eustachian
tube
consid
sanctuari
site
bacteri
pathogen
cytokin
may
predispos
recurr
lower
airway
infect
final
variat
host
inflammatori
respons
exampl
cytokin
metalloproteinas
level
counterbalanc
antiinflammatori
mechan
exampl
antioxid
antiproteas
may
explain
children
develop
bronchiectasi
other
despit
similar
exposur
live
condit
well
document
acut
lower
respiratori
tract
infect
alri
children
lead
subsequ
respiratori
morbid
lung
function
abnorm
classic
epidemiolog
studi
link
acut
alri
adenoviru
infect
chronic
bronchiti
product
cough
later
childhood
recent
larg
epidemiolog
studi
also
shown
alri
earli
childhood
risk
lower
lung
function
adulthood
although
low
lung
function
birth
may
underli
die
attend
singl
new
zealand
center
prematur
mortal
bronchiectasi
may
carri
young
adulthood
particularli
circumst
nonoptim
manag
depict
retrospect
cohort
studi
central
australian
indigen
adult
bronchiectasi
diagnos
children
hospit
report
die
period
median
age
year
uk
recent
studi
describ
crude
mortal
men
age
year
bronchiectasi
ci
per
popul
women
compar
gener
popul
rate
respect
repres
excess
mortal
rate
time
gener
popul
littl
data
econom
cost
bronchiectasi
none
specif
children
unit
statesbas
casecontrol
studi
involv
children
adult
age
year
direct
medic
cost
increas
us
per
patient
per
year
rel
match
control
preced
year
cost
specif
children
describ
earlier
studi
found
unit
state
adult
bronchiectasi
averag
ci
addit
day
hospit
averag
total
annual
medicalcar
expenditur
us
higher
bronchiectasi
patient
age
gender
match
control
chronic
diseas
diabet
copd
congest
heart
failur
recent
year
four
pediatr
studi
three
differ
contin
evalu
impact
bronchiectasi
child
andor
parent
healthrel
qualiti
life
qol
use
parent
coughspecif
qualiti
life
pcqol
depress
anxieti
stress
questionnair
malaysian
studi
describ
children
cf
better
parent
mental
health
compar
children
noncf
csld
overal
parent
abnorm
score
stress
depress
australian
studi
examin
pcqol
score
stablest
exacerb
children
median
age
year
parent
stabl
state
median
pcqol
interquartil
rang
iqr
score
significantli
wors
exacerb
pcqol
p
dass
p
dass
score
show
elev
anxieti
abnorm
depressionstress
score
exacerb
stabl
state
poorer
qol
significantli
record
younger
children
qol
relat
radiolog
extent
lung
function
underli
etiolog
contrast
turkish
studi
describ
sever
frequenc
symptom
invers
relat
pulmonari
function
qol
score
nonpediatr
scale
use
children
age
year
anoth
turkish
studi
involv
caucasian
children
bronchiectasi
control
use
selfreport
questionnair
evalu
psycholog
statu
use
child
depress
inventori
statetrait
anxieti
inventori
children
pediatr
qualiti
life
inventori
older
cohort
children
mean
age
five
episod
pneumonia
time
like
pneumonia
overal
number
pneumonia
rather
site
pneumonia
associ
bronchiectasi
alaskan
cohort
associ
lobe
affect
first
alri
eventu
bronchiectat
lobe
associ
lobe
sever
affect
alri
lobe
later
affect
bronchiectasi
specif
infecti
etiolog
describ
studi
review
longterm
effect
pneumonia
young
children
describ
mixtur
obstruct
restrict
lung
deficit
follow
long
term
howev
major
studi
review
limit
case
ascertain
followup
issu
author
suggest
bronchiol
import
precursor
bronchiectasi
alaskan
casecontrol
followup
children
hospit
infanc
specif
sever
rsv
infect
describ
like
diagnos
bronchiectasi
contrast
studi
indigen
children
hospit
bronchiol
australia
found
ct
scan
perform
median
month
rang
factor
signific
associ
found
singl
sever
alri
multipl
alri
earli
childhood
undoubtedli
lead
csld
bronchiectasi
singl
alri
associ
bronchiectasi
describ
tuberculosi
pertussi
adenoviru
measl
sever
viral
pneumonia
although
infect
frequent
caus
bronchiectasi
remain
common
alri
less
affluent
countri
still
consid
import
anteced
childhood
bronchiectasi
cohort
studi
common
associ
caus
ascrib
etiolog
bronchiectasi
past
pneumon
event
lobar
diffus
alveolar
infiltr
see
tabl
sole
casecontrol
studi
childhood
pneumonia
radiograph
proven
bronchiectasi
strong
associ
hospit
pneumonia
bronchiectasi
found
children
previous
hospit
due
pneumonia
time
like
develop
bronchiectasi
dose
effect
also
shown
recurr
hospit
pneumonia
sever
pneumonia
episod
longer
hospit
stay
oxygen
requir
increas
risk
bronchiectasi
later
childhood
bronchiectasi
time
like
children
four
condit
develop
anaerob
pulmonari
infect
six
poor
oral
hygien
field
wrote
irrevers
bronchiectasi
commonli
seen
better
social
econom
class
good
nutrit
home
condit
probabl
give
child
better
chanc
complet
recoveri
lung
damag
diseas
poor
public
health
condit
includ
malnutrit
crowd
lack
run
water
environment
pollut
increas
risk
alri
bronchiti
issu
particularli
import
develop
countri
affluent
countri
commun
higher
preval
bronchiectasi
also
poverti
low
standard
hous
common
qualit
studi
commun
member
health
care
provid
believ
potenti
contribut
factor
acut
chronic
lung
diseas
smoke
dust
feed
practic
socioeconom
condit
mold
macro
select
micro
malnutrit
increas
infect
risk
creat
immun
defici
state
lead
malnutritioninfectionmalnutrit
cycl
howev
data
malnutrit
specif
preced
bronchiectasi
limit
inconsist
central
australia
indigen
children
bronchiectasi
time
like
malnutrit
earli
childhood
prior
diagnosi
bronchiectasi
seen
alaska
new
zealand
breastfeed
known
protect
factor
develop
bronchiectasi
bronchiectasi
may
predispos
malnutrit
result
chronic
pulmonari
infect
diminish
appetit
reduc
calor
intak
calor
need
daili
oxygen
consumpt
children
noncfrel
bronchiectasi
report
one
seri
describ
children
bronchiectasi
low
baselin
fev
predict
valu
posthospit
infant
persist
cough
week
n
hospit
significantli
like
bronchiectasi
compar
without
cough
n
ci
p
surmis
bronchiectasi
consequ
specif
virus
produc
bronchiol
mechan
upper
respiratori
infect
predispos
lower
airway
inflamm
injuri
review
elsewher
bacteri
pathogen
colon
nose
mouth
shed
saliva
contamin
lower
airway
proinflammatori
cytokin
oropharynx
may
also
aspir
augment
neutrophil
respons
lower
airway
hydrolyt
enzym
infect
upper
airway
secret
impair
protect
secretori
molecul
mucin
lower
airway
therebi
predispos
lower
airway
infect
vitro
studi
shown
bacteria
produc
factor
caus
ciliari
slow
dyskinesia
stasi
set
stage
chronic
bacteri
colon
lower
airway
whether
concentr
persist
pathogen
upper
airway
repres
signific
risk
factor
develop
progress
bronchiectasi
unknown
indigen
australian
children
bronchiectasi
studi
relat
nasopharyng
bronchoalveolar
lavag
bal
bacteria
found
high
densiti
divers
respiratori
bacteria
along
strain
concord
upper
lower
airway
studi
suggest
possibl
pathogen
role
recurr
aspir
nasopharyng
secret
bronchiectasi
form
suppur
lung
diseas
describ
among
individu
neurolog
neuromuscular
condit
reduc
frequenc
effect
cough
also
increas
risk
aspir
oropharyng
content
brook
report
children
although
studi
call
systemat
review
review
incomplet
sever
studi
omit
cf
cystic
fibrosi
gerd
gastroesophag
reflux
diseas
bronchiectasi
certain
children
increas
exagger
neutrophil
respons
australian
indigen
children
group
describ
similarli
metalloproteinas
exampl
isol
sputum
bal
bronchiectat
subject
suggest
role
airway
destruct
gelatinas
collagenas
whether
proinflammatori
cytokin
collagenas
overexpress
associ
earli
onset
diseas
particularli
progress
diseas
childhood
remain
unknown
histopatholog
bronchiectasi
first
describ
includ
alter
subsegment
bronchial
structur
accompani
neutrophil
inflamm
intralumin
secret
accumul
obliter
distal
airway
accompani
chang
peribronchi
inflamm
fibrosi
distal
lung
collaps
bronchial
pulmonari
vascular
chang
pleural
adhes
macroscop
microscop
featur
bronchiectasi
chang
diseas
progress
classic
paper
bronchiectasi
divid
morpholog
type
bronchiectasi
tubular
cylindr
earli
fusiform
late
fusiform
fusosaccular
saccular
type
differ
stage
progress
diseas
commonli
use
classif
reid
subtyp
cylindr
varicos
cystic
base
bronchograph
find
latter
find
illustr
fig
reflect
progress
increas
sever
recent
hrct
score
system
describ
cylindr
saccular
chang
marker
diseas
sever
saccular
cystic
chang
tend
reflect
clinic
advanc
sever
irrevers
diseas
macroscop
airway
tortuou
dilat
time
extend
pleural
surfac
earli
histolog
chang
includ
bronchial
wall
thicken
edema
presenc
inflammatori
cell
develop
lymphoid
nodul
follicl
mucu
gland
hyperplasia
intralumin
secret
purul
mucopurul
video
microscop
chang
includ
loss
ciliat
epitheli
cell
epitheli
ulcer
time
chronic
inflamm
lead
squamou
cell
metaplasia
fibrot
obliter
distal
conduct
immunodefici
significantli
lower
bodi
mass
index
diagnosi
significantli
improv
appropri
therapi
institut
also
doubleblind
random
control
trial
effect
longterm
azithromycin
indigen
children
random
azithromycin
group
cf
placebo
signific
improv
weight
zscore
concurr
reduct
exacerb
incid
rate
ratio
ci
suggest
effect
manag
children
bronchiectasi
improv
nutrit
anoth
predispos
factor
bronchiectasi
presenc
inhal
irrit
includ
indoor
outdoor
pollut
particularli
presenc
impair
airway
clearanc
effect
environment
tobacco
smoke
et
children
respiratori
system
well
known
utero
ex
utero
exposur
includ
reduc
airway
calib
increas
lower
respiratori
tract
infect
middl
ear
diseas
review
et
effect
develop
lung
acceler
lung
declin
avail
elsewher
exposur
indoor
biomass
combust
increas
cough
ill
associ
alri
exposurerespons
effect
exposur
indoor
pollut
nitrogen
dioxid
ga
cook
traffic
also
associ
increas
cough
children
crosssect
longitudin
studi
direct
evid
pollut
caus
bronchiectasi
pathogen
role
like
indirect
increas
frequenc
alri
increas
airway
mucu
product
chile
increas
arsen
exposur
associ
varieti
chronic
disord
includ
bronchiectasi
interplay
genotyp
epigenet
environ
increasingli
recogn
key
phenotyp
express
respiratori
diseas
increas
frequenc
cystic
fibrosi
transmembran
conduct
regul
cftr
genotyp
associ
cf
present
heterozygot
describ
sever
case
seri
adult
diffus
bronchiectasi
heterozygot
antitrypsin
also
describ
frequent
individu
diffus
bronchiectasi
causal
relationship
remain
controversi
older
guidelin
suggest
option
screen
antitrypsin
defici
patient
idiopath
diffus
bronchiectasi
newer
guidelin
describ
lack
evid
suggest
antitrypsin
defici
test
peopl
bronchiectasi
turkish
studi
consanguin
parent
common
describ
transport
associ
antigen
present
tap
gene
polymorph
cohort
children
bronchiectasi
interest
note
high
rate
consanguin
sever
seri
children
bronchiectasi
differ
countri
diseas
increas
number
gene
aberr
associ
syndrom
bronchiectasi
may
occur
exampl
includ
primari
ciliari
dyskinesia
autosom
domin
polycyst
kidney
diseas
chromosom
chromosom
prolidas
defici
pepd
gene
asid
variat
specif
gene
frequenc
overexpress
innat
pulmonari
immun
mechan
proinflammatori
cytokin
adhes
molecul
product
receptor
express
may
contribut
develop
bronchiectasi
produc
local
injuri
rather
underli
defici
pulmonari
host
defens
role
bacteria
pathogenesi
chronic
lung
infect
bronchiectasi
review
elsewher
major
studi
airway
inflamm
perform
adult
unlik
children
assess
use
sputum
easi
airway
secret
usual
excess
sever
bronchiectasi
sputa
alaskan
nativ
children
stabl
idiopath
bronchiectasi
less
viscou
onethird
less
elast
onefifth
less
adhes
half
transport
compar
sputum
children
cf
neutrophilia
domin
type
airway
inflamm
although
eosinophilia
also
describ
popul
treat
airway
inflamm
may
absent
increas
percentag
neutrophil
neutrophil
elastas
myeloperoxidas
mellatoproteinas
tumor
necrosi
interleukin
describ
lower
airway
secret
gener
reflect
neutrophil
inflamm
specif
bronchiectasi
intens
airway
system
inflamm
amelior
treatment
adult
cohort
involv
patient
describ
direct
relationship
airway
bacteri
load
marker
airway
inflamm
myeloperoxidas
neutrophil
elastas
dose
respons
higher
inflamm
correl
higher
bacteri
load
high
bacteri
load
associ
higher
serum
intercellular
adhes
eselectin
vascular
cell
adhes
reflect
system
inflamm
use
short
day
long
month
term
antibiot
treatment
studi
demonstr
signific
reduct
airway
bacteri
load
inflamm
airway
system
compar
receiv
antibiot
therapi
howev
poor
correl
system
bronchial
inflammatori
mediat
suggest
inflammatori
process
mostli
compartment
airway
pauciti
data
bal
sputum
marker
children
small
studi
children
describ
increas
median
valu
system
marker
white
cell
creactiv
protein
crp
fibrinogen
children
whose
airway
colon
n
compar
without
identifi
bacteria
sputum
white
cell
count
author
conclud
system
inflamm
absent
children
bronchiectasi
compar
control
highli
like
error
present
studi
indepth
studi
blood
children
bronchiectasi
signific
increas
percentag
cell
natur
killer
tcell
nkt
like
subset
express
perforin
granzym
interferon
gamma
compar
control
proinflammatori
cytotox
cell
mark
indigen
children
compar
nonindigen
children
exagger
persist
pulmonari
inflamm
present
bronchiectasi
lead
increas
lung
destruct
mani
mechan
balanc
proteas
airway
peribronchi
tissu
bronchiectasi
becom
sever
airway
wall
becom
thin
saccular
destruct
airway
muscular
elast
cartilagin
element
saccular
airway
wall
compos
fibrou
granul
tissu
remnant
normal
tissu
advanc
diseas
mucusfil
saccular
airway
chang
sever
enough
appear
cystic
microabscess
vascular
chang
accompani
bronchial
structur
chang
bronchiectasi
larg
bronchopulmonari
anastomosi
develop
total
bronchial
arteri
blood
flow
increas
extens
precapillari
anastomos
two
arteri
system
serv
shunt
pulmonari
system
system
increas
cardiac
work
bronchopulmonari
vascular
anastomos
often
occur
near
distal
subsegment
bronchi
undergon
saccular
chang
abnorm
bronchopulmonari
anastomos
enlarg
aberr
bronchial
arteri
thought
associ
metabol
demand
hypertrophi
muscl
lymphoid
tissu
peribronchi
granul
tissu
cours
organ
pneumon
preced
develop
bronchiectasi
presenc
signific
hemoptysi
like
relat
abnorm
addit
vascular
remodel
pulmonari
arteri
arteriol
occur
associ
chronic
airway
obstruct
alveolar
hypoxia
predispos
patient
pulmonari
hypertens
cor
pulmonal
sever
case
initi
trigger
bronchiectasi
process
unknown
littl
doubt
host
pathogen
factor
play
role
fig
anim
model
bronchiectasi
suggest
inadequ
mucu
clearanc
persist
infect
necessari
prerequisit
mucu
clearanc
bronchiectasi
reduc
combin
factor
includ
airflow
limit
abnorm
quantiti
qualiti
mucu
produc
factor
produc
bacteria
caus
ciliari
slow
dyskinesia
mucu
stasi
mucociliari
clearanc
enhanc
cough
exercis
hyperventil
decreas
situat
airway
calib
diminish
decreas
mucociliari
clearanc
turn
lead
increas
bacteri
colon
infect
set
viciou
cycl
concept
schemat
present
fig
importantli
reduc
mucociliari
clearanc
local
affect
region
degrad
proteoglycan
matrix
model
proteas
secret
stimul
presenc
factor
found
sputum
sol
addit
pathogen
process
associ
bronchiectasi
contribut
persist
airway
inflamm
obstruct
increas
airway
permeabl
also
describ
bronchiectasi
purul
sputum
signific
colon
respiratori
tract
bacteri
pathogen
present
also
resolut
inflamm
normal
associ
orderli
remov
apoptot
inflammatori
cell
impair
remov
apoptot
inflammatori
cell
describ
children
adult
bronchiectasi
pediatr
studi
also
examin
specif
phagocyt
activ
nontyp
haemophilu
influenza
nthi
wherea
adult
studi
investig
apoptosi
relat
inflamm
adult
studi
report
impair
apoptosi
occur
doserespons
fashion
increas
neutrophil
elastas
marker
neutrophil
inflamm
children
bronchiectasi
macrophag
phagocyt
capac
bal
cell
apoptot
cell
efferocytosi
nthi
significantli
lower
control
efferocytosi
iqr
vs
antiproteas
increasingli
recogn
import
protect
airway
hostil
agent
destruct
lung
tissu
upregul
circul
adhes
molecul
eselectin
vascular
adhes
molecul
also
suggest
play
role
pathogenesi
bronchiectasi
collagenas
activ
present
bal
adult
moder
sever
bronchiectasi
origin
neutrophil
bacteria
collagenolyt
proteas
like
contributor
tissu
destruct
describ
airway
peopl
bronchiectasi
contain
collagenolyt
proteinas
bacteri
origin
neutrophilicassoci
cytokin
unab
lead
increas
tissu
damag
eg
metalloproteinas
tissu
inhibitor
measur
exhal
breath
condens
children
noncf
bronchiectasi
ngml
similar
cf
significantli
higher
control
endobronchi
biopsi
adult
bronchiectasi
demonstr
overexpress
neutrophil
matrix
metalloproteinas
mmp
affect
region
reduc
oxygen
satur
abnorm
cardiac
sound
associ
pulmonari
hypertens
late
sign
bronchiectasi
similar
seriou
chronic
respiratori
ill
children
bronchiectasi
may
growth
failur
associ
delay
diagnosi
bronchiectasi
median
age
diagnosi
bronchiectasi
unrel
cf
affluent
countri
year
new
zealand
cohort
older
year
old
diagnosi
also
experienc
advanc
diseas
idiopath
bronchiectasi
rare
infanc
present
like
reflect
congenit
pulmonari
malform
cystic
lung
diseas
tracheobronchomegali
altern
primari
ciliari
dyskinesia
ciliari
dyskinesia
kartagen
triad
situ
inversu
bronchiectasi
sinus
radiolog
risk
factor
develop
bronchiectasi
presenc
atelectasi
persist
lobar
abnorm
alaska
children
like
develop
bronchiectasi
chest
radiograph
obtain
children
less
year
age
show
lung
parenchym
densiti
persist
parenchym
densiti
greater
month
durat
repeat
parenchym
densiti
among
aborigin
australian
children
hospit
lobar
chang
admiss
chest
radiograph
children
alveolar
abnorm
like
bronchiectasi
followup
prospect
radiograph
studi
alveolar
chang
lobe
hospit
children
two
common
involv
lobe
right
upper
lobe
left
lower
lobe
lobe
similar
rate
radiolog
clearanc
followup
respect
children
postinfecti
bronchiol
obliteran
csld
share
common
clinic
featur
airway
obstruct
chronic
cough
recurr
alri
addit
etiolog
insult
australian
studi
children
postinfecti
bo
develop
bronchiectasi
south
american
cohort
followup
studi
mean
period
year
sd
describ
mean
fvc
increas
year
ci
fev
year
ci
fev
fvc
ratio
decreas
year
ci
seventyeight
percent
children
cohort
bronchiectasi
phenotyp
childhood
wheez
recogn
airway
hyperreact
occur
individu
bronchiectasi
presenc
featur
asthma
describ
bad
prognost
factor
children
adult
bronchiectasi
frequenc
airway
hyperreact
children
bronchiectasi
vari
corollari
clinician
must
recogn
wheez
cough
may
relat
asthma
increas
airway
secret
airway
collaps
featur
bronchiectasi
gastroesophag
reflux
diseas
gerd
may
coexist
chronic
respiratori
ill
appropri
treat
howev
data
adult
indic
gerd
may
resolv
significantli
improv
underli
respiratori
disord
treat
howev
evidencebas
approach
manag
gerd
associ
bronchiectasi
caution
necessari
regard
iqr
respect
p
nthi
iqr
vs
iqr
respect
p
mannos
receptor
express
bal
also
found
significantli
reduc
bronchiectasi
group
compar
control
p
innat
defens
mechan
also
play
role
pathogenesi
upregul
respons
infect
peopl
bronchiectasi
howev
littl
data
specif
children
studi
involv
children
human
immunodefici
viru
hiv
relat
bronchiectasi
solubl
trigger
receptor
express
myeloid
innat
immun
marker
upregul
highli
express
children
cf
also
correl
neutrophil
elastas
deriv
bal
increas
express
innat
immun
receptor
eg
receptor
cytokin
respons
eg
seen
adult
bronchiectasi
also
found
neutrophil
asthma
children
pbb
like
forerunn
bronchiectasi
rais
possibl
peopl
neutrophil
asthma
unrecogn
csld
inde
mani
children
pbb
previous
misdiagnos
asthma
set
classifi
difficult
sever
asthma
emerg
bodi
evid
impair
cellmedi
immun
respons
dysregul
airway
inflamm
link
could
contribut
pathobiolog
csld
studi
system
immun
found
children
csld
bronchiectasi
produc
significantli
less
respons
nthi
healthi
control
children
wherea
mitogeninduc
product
similar
group
product
system
nthispecif
significantli
neg
associ
bal
p
p
presenc
bacteri
viral
infect
sever
bronchiectasi
use
modifi
ct
bhalla
score
influenc
system
nthispecif
respons
clinic
case
definit
bronchiectasi
imprecis
diagnosi
consid
children
chronic
wet
sound
product
cough
without
exert
dyspnea
recurr
wheez
chest
infect
hemoptysi
growth
failur
club
hyperinfl
common
symptom
persist
recurr
wet
product
cough
purul
mucopurul
sputum
sputum
color
reflect
neutrophil
airway
inflamm
frequenc
chest
wall
deform
hyperinfl
digit
club
vari
among
case
seri
digit
club
disappear
medic
surgic
treatment
associ
disappear
purul
sputum
although
hemoptysi
much
less
common
among
children
adult
bronchiectasi
present
find
hemoptysi
rais
possibl
airway
bleed
due
bronchiectasi
chest
auscult
may
entir
normal
reveal
coars
inspiratori
crackl
find
also
present
condit
box
chrct
sign
bronchiectasi
includ
abnorm
surround
lung
may
includ
parenchyma
loss
emphysema
scar
nodular
foci
linear
array
cluster
cyst
dilat
bronchi
peripheri
lung
bronchial
wall
thicken
box
imag
qualiti
henc
detect
bronchiectasi
depend
radiolog
techniqu
use
tube
set
radiat
dose
collim
distanc
imag
interv
fals
posit
fals
neg
situat
may
occur
list
box
hrct
differenti
etiolog
bronchiectasi
overdiagnosi
unnecessari
treatment
gerd
given
increas
evid
increas
risk
respiratori
infect
children
adult
receiv
proton
pump
inhibitor
commun
hospit
cohort
reader
refer
pediatr
guidelin
diagnosi
treatment
gerd
hypertroph
osteoarthropathi
club
periostosi
tubular
bone
arthritislik
sign
symptom
may
occur
children
bronchiectasi
system
amyloidosi
also
report
complic
comorbid
cardiac
dysfunct
although
rare
also
report
may
accompani
pulmonari
hypertens
studi
children
bronchiectasi
show
ventricular
systol
function
normal
patient
chang
left
ventricular
diastol
function
author
also
found
isovolumetr
relax
time
signific
neg
correl
clinic
sever
score
report
comorbid
condit
associ
bronchiectasi
osteopenia
scoliosi
chronic
suppur
ear
diseas
social
problem
past
urinari
tract
infect
development
delay
adult
vitamin
defici
report
associ
increas
sever
bronchiectasi
chronic
bacteri
colon
airway
howev
serum
vitamin
neg
acut
phase
reactant
ie
valu
fall
increas
inflamm
deciph
caus
effect
problemat
goal
evalu
children
suspect
bronchiectasi
confirm
diagnosi
defin
distribut
sever
airway
involv
character
extrapulmonari
organ
involv
associ
bronchiectasi
cor
pulmonal
identifi
famili
treatabl
underli
caus
bronchiectasi
contributor
progress
chest
hrct
gold
standard
diagnosi
plain
chest
radiograph
insensit
long
recogn
chest
xray
normal
peopl
bronchiectasi
modern
ct
scanner
imag
best
acquir
use
mdct
scan
hrct
reconstruct
provid
best
sensit
scan
protocol
must
childappropri
minim
radiat
risk
radiolog
center
inexperienc
deal
children
often
util
adult
protocol
subject
children
higher
dose
radiat
radiolog
featur
bronchiectasi
also
occur
associ
pulmonari
fibrosi
congenit
lesion
mounierkuhn
williamscampbel
syndrom
result
traction
nonsuppur
lung
diseas
characterist
radiograph
find
hrct
bronchiectasi
presenc
signet
ring
dilat
bronchu
greater
diamet
accompani
blood
vessel
cross
section
fig
howev
cutoff
wherebi
ratio
consid
abnorm
reduc
children
csld
symptom
present
gener
appreci
pulmonologist
radiologist
may
still
use
adult
criteria
presenc
bronchial
dilat
rel
accompani
vessel
alway
equat
presenc
bronchiectasi
investig
mani
retain
label
idiopath
presum
postinfecti
bronchiectasi
see
tabl
difficulti
ascrib
etiolog
csldbronchiectasi
aris
due
unavail
certain
test
exampl
function
test
ciliari
motil
extend
immun
test
lack
standard
approach
diagnosi
popul
studi
ct
definit
use
identifi
etiolog
assess
diseas
sever
influenc
surveil
frequenc
treatment
intens
prognosi
investig
specif
caus
csld
bronchiectasi
recommend
even
though
mani
patient
lack
identifi
etiolog
current
best
practic
investig
possibl
etiolog
outlin
tabl
diagnosi
ciliari
dyskinesia
address
anoth
chapter
see
chapter
bronchoscopi
indic
identifi
obstruct
bronchiectasi
intralumin
tumor
foreign
bodi
wall
tracheobronchomalacia
tbm
extramur
extern
airway
compress
bronchiectasi
complic
inhal
foreign
bodi
occur
among
patient
whose
diagnosi
aspir
delay
greater
day
prospect
studi
involv
children
bronchiectasi
undergo
flexibl
bronchoscopi
occas
children
bronchoscop
result
alter
empir
treatment
bal
microbiolog
result
led
antibiot
chang
five
children
unsuspect
foreign
bodi
found
one
bronchoscop
find
major
airway
relat
bronchiectasi
describ
five
type
type
mucos
patient
usual
diagnos
bronchiectasi
mani
year
symptom
may
difficult
defin
etiolog
differenti
idiopath
postinfecti
bronchiectasi
particularli
problemat
common
featur
mani
patient
impair
local
system
host
defens
infect
often
caus
found
even
extens
limit
cardiopulmonari
exercis
test
relat
hrct
score
limit
data
bronchiectasi
alter
respiratori
system
resist
reactanc
measur
forc
oscillatori
techniqu
fot
children
indic
obtain
impuls
oscillometri
exacerb
significantli
differ
stabl
state
stabl
state
resist
hz
poorli
sensit
lung
diseas
children
cf
indic
fot
insensit
baselin
also
detect
lung
progress
month
anoth
tool
assess
sever
bronchiectasi
lung
clearanc
index
lci
lci
reflect
ventil
inhomogen
peripher
airway
data
children
cf
suggest
lci
chang
occur
earli
physiolog
measur
evalu
lung
damag
among
adult
stabl
noncf
bronchiectasi
lci
neg
correl
fev
predict
abnorm
often
howev
studi
involv
pair
measur
adult
noncf
bronchiectasi
found
lci
less
sensit
fev
evalu
improv
treatment
intraven
antibiot
physiotherapi
respiratori
exacerb
fev
vital
capac
significantli
improv
signific
chang
lci
intraven
antibiot
physiotherapi
studi
also
undertook
pair
measur
adult
stabl
bronchiectasi
describ
lci
indic
reproduc
compar
control
lci
significantli
higher
studi
children
noncf
bronchiectasi
know
sensit
earli
diseas
least
eight
radiograph
score
system
assess
sever
bronchiectasi
use
plain
abnormalityinflamm
type
ii
bronchomalacia
fig
type
iii
obliterativelik
fig
type
iv
malaciaobliterativelik
combin
type
v
abnorm
frequenc
find
among
children
noncf
bronchiectasi
type
v
respect
children
postinfecti
bronchiectasi
csld
structur
airway
lesion
present
retrospect
studi
involv
greek
children
year
describ
type
iii
ci
type
iv
ci
bronchoscop
lesion
significantli
correl
wors
radiolog
score
reflect
sever
correl
percentag
bal
neutrophil
r
p
bronchomalacia
associ
bronchiectasi
relat
chronic
inflamm
although
unknown
bronchomalacia
predat
recurr
respiratori
infect
airway
mucos
chang
typic
chronic
bronchiti
usual
present
bronchiectat
airway
bronchoscopi
bronchoscop
find
includ
atroph
mucosa
increas
secret
airway
friabil
airway
flaccid
hypertrophi
element
wall
longitudin
corrug
mucos
redden
increas
vascular
dilat
duct
displac
due
lobar
collaps
also
describ
proxim
conduct
airway
fig
pulmonari
function
children
spirometri
insensit
detect
earli
structur
lung
damag
children
bronchiectasi
cf
noncf
spirometr
valu
may
normal
spirometr
abnorm
present
usual
obstruct
earlier
stage
becom
mix
obstruct
restrict
process
bronchiectasi
sever
although
fev
correl
chest
hrct
abnorm
popul
sensit
measur
especi
bronchiectasi
local
fev
also
normal
cf
earli
stage
diseas
even
radiolog
bronchiectasi
present
howev
bronchiectasi
diffus
spirometr
abnorm
although
insensit
diseas
activ
reflect
diseas
sever
pulmonari
function
test
abnorm
describ
high
residu
volum
lower
aerob
capac
lower
maxim
ventil
maxim
exercis
effort
expector
sputum
even
substanti
lower
airway
secret
henc
young
children
assess
lower
airway
microbiolog
requir
bronchoscopi
obtain
bal
lower
airway
sampl
bal
remain
gold
standard
although
criteria
defin
infect
remain
controversi
studi
gener
use
threshold
bacteri
growth
coloni
form
unit
cfu
ml
bal
indic
infect
method
identifi
airway
pathogen
children
bronchiectasi
oropharyng
nasopharyng
swab
induc
sputum
adult
bronchiectasi
sputum
cultur
gener
reflect
lower
airway
organ
obtain
bronchoscop
cathet
protect
brush
one
studi
children
bronchiectasi
describ
sensit
neg
predict
valu
nasopharyng
cultur
individu
respiratori
bacteri
pathogen
caus
lower
airway
infect
use
bal
comparison
rang
specif
posit
predict
valu
lower
common
respiratori
pathogen
children
bronchiectasi
streptococcu
pneumonia
h
influenza
nontyp
b
organ
includ
moraxella
catarh
pseudomona
aeruginosa
pediatr
bronchiectasi
pathogen
isol
rate
sputum
bal
pseudomona
commonli
found
adult
sever
bronchiectasi
uncommon
children
adolesc
bronchiectasi
sever
adult
systemat
review
found
persist
pseudomona
endobronchi
infect
associ
increas
diseas
sever
measur
radiograph
spirometri
death
threefold
hospit
poorer
qol
data
children
nontubercul
mycobacteria
aspergillu
commonli
found
adult
bronchiectasi
rare
present
children
bronchiectasi
number
children
bronchiectasi
persist
colon
potenti
pathogen
microorgan
largest
studi
report
microbiolog
children
bronchiectasi
undertaken
clinic
stabl
h
influenza
identifi
pneumonia
catarrhali
aureu
bal
cultur
p
aeruginosa
present
seven
children
six
bronchiectasi
involv
multipl
lobe
five
comorbid
studi
also
report
respiratori
virus
princip
respiratori
syncyti
viru
adenoviru
present
children
codetect
respiratori
pathogen
found
half
posit
microbiolog
result
adenoviru
genotyp
almost
type
c
presenc
adenoviru
significantli
associ
bacteri
coinfect
h
influenza
catarrhali
pneumonia
ci
neg
associ
aureu
infect
p
bal
studi
microbiota
use
bacteri
rrna
gene
pyrosequenc
children
adult
bronchiectasi
report
howev
impact
clinic
manag
yet
defin
nevertheless
one
studi
compar
microbiota
children
adult
bronchiectasi
report
respiratori
microbiota
significantli
differ
pulmonari
exacerb
among
children
noncf
bronchiectasi
often
trigger
virus
increas
film
howev
given
insensit
chest
radiograph
detect
bronchiectasi
score
system
supersed
chest
hrct
score
system
describ
webb
et
al
bhalla
et
al
reiff
et
al
chest
hrct
score
system
base
composit
score
multipl
radiolog
find
system
util
expiratori
scan
other
webb
composit
score
summat
score
sever
extent
featur
emphysema
consolidationatelectasi
bhalla
score
compris
sum
score
assign
nine
categori
sever
bronchiectasi
peribronchi
thicken
extent
bronchiectasi
extent
mucu
plug
saccul
gener
bronchi
involv
number
bulla
emphysema
collapseconsolid
one
studi
compar
three
score
system
group
children
noncf
bronchiectasi
correl
score
rang
none
relat
fev
valu
magnet
reson
imag
mri
emerg
techniqu
assess
bronchiectasi
current
poorer
ct
evalu
airway
diseas
marker
uk
group
develop
bronchiectasi
sever
index
adult
stratif
tool
morbid
mortal
index
includ
featur
rare
children
eg
fev
predict
thu
use
children
world
omic
bloom
current
studi
relev
clinic
care
bronchiectasi
children
cf
metabolom
use
mass
spectrometri
describ
possibl
biomark
bal
neutrophil
inflamm
techniqu
expir
breath
analysi
breath
condens
measur
describ
almost
two
decad
ago
advanc
bronchiectasi
date
littl
research
sensit
appropri
method
assess
progress
bronchiectasi
children
clinician
reli
frequenc
respiratori
exacerb
daili
clinic
symptom
may
perceiv
differ
children
parent
bronchiectasi
sever
score
children
qol
score
specif
cough
use
children
bronchiectasi
date
pediatr
bronchiectasisspecif
qol
score
sensit
object
assess
earli
diseas
progress
base
hrct
chang
preced
pulmonari
function
chang
howev
repeat
hrct
scan
recommend
pure
assess
diseas
progress
given
known
risk
radiat
young
children
assess
diseas
progress
includ
chest
radiograph
insensit
lung
function
marker
neutrophil
airway
inflamm
possibl
assess
airway
proteas
one
small
crosssect
studi
show
signific
correl
hrct
sever
score
symptom
fev
sputum
level
r
valu
respect
howev
data
relat
airway
marker
imag
assess
longitudin
diseas
progress
sputum
sampl
easiest
method
obtain
endobronchi
microbiolog
profil
young
children
often
author
field
emphas
import
treatment
even
simpl
medic
treatment
progress
case
bronchiectasi
secondari
cf
primari
ciliari
dyskinesia
aggress
manag
infect
antimicrobi
regular
use
airway
clearanc
method
attent
nutrit
coupl
vigil
monitor
longterm
clinic
trend
proactiv
care
led
improv
surviv
preserv
lung
function
cf
produc
specif
type
progress
bronchiectasi
differ
form
bronchiectasi
respect
mucu
rheolog
airway
surfac
abnorm
salt
content
airway
microbi
pathogen
extrapulmonari
organ
involv
although
blind
extrapol
manag
use
cf
noncf
bronchiectasi
harm
manag
children
bronchiectasi
arguabl
intens
children
idiopath
bronchiectasi
minim
acut
exacerb
daili
symptom
function
limit
thu
improv
prognosi
inde
recent
data
provid
evid
intens
treatment
children
either
bronchiectasi
risk
develop
sever
bronchiectasi
prevent
poor
lung
function
adulthood
even
among
children
seriou
underli
condit
congenit
immunodefici
bronchiectasi
comprehens
regular
care
surveil
program
delay
declin
lung
function
period
year
aim
regular
review
includ
optim
postnat
lung
growth
prevent
prematur
respiratori
declin
maxim
qol
prevent
complic
due
bronchiectasi
issu
requir
regular
monitor
list
box
ideal
team
approach
incorpor
alli
health
expertis
nurs
physiotherapi
nutritionist
social
work
use
model
shown
improv
health
outcom
sever
chronic
diseas
evidencebas
guidelin
manag
bronchiectasi
children
publish
sinc
subsequ
updat
adult
includ
umbrella
cochran
review
intervent
bronchiectasi
publish
densiti
known
bacteri
pathogen
sputum
singl
prospect
studi
children
evalu
point
preval
virus
associ
exacerb
report
respiratori
virus
detect
exacerb
one
publish
studi
develop
standard
definit
exacerb
children
children
child
month
studi
describ
valid
major
minor
criteria
use
hospit
primari
care
set
major
criteria
presenc
wet
cough
cough
sever
score
minor
criteria
chang
sputum
color
chest
pain
dyspnea
hemoptysi
new
chest
sign
physic
examin
inclus
investig
investigatori
criteria
elev
serum
creactiv
protein
amyloida
definit
improv
specif
posit
predict
valu
infrequ
featur
import
reduc
exercis
toler
energi
fever
hemoptysi
uncommon
exacerb
bronchiectasi
pediatr
age
group
determin
acceler
lung
function
declin
adult
bronchiectasi
frequenc
hospit
exacerb
increas
system
inflammatori
marker
colon
p
aeruginosa
one
studi
children
interv
signific
predictor
fev
declin
frequenc
hospit
exacerb
exacerb
fev
predict
decreas
adjust
time
like
intervent
reduc
exacerb
prevent
lung
dysfunct
also
exacerb
particularli
recurr
one
strongest
predictor
poor
qol
among
adult
bronchiectasi
prospect
studi
involv
indigen
children
alaska
australia
show
factor
associ
recurr
exacerb
includ
age
less
year
respiratoryrel
hospit
first
year
life
pneumonia
hospit
exacerb
year
preced
enrol
studi
also
report
clinic
care
time
exacerb
occur
less
frequent
exacerb
treat
end
treatment
improv
cough
charact
gener
wellb
qol
indic
inflammatori
marker
reduc
sputum
volum
purul
decreas
sputum
bacteri
load
pathogen
clearanc
return
toward
patient
stabl
baselin
state
earli
role
todd
emphas
import
earli
diagnosi
treatment
reduc
mortal
associ
bronchiectasi
adher
reduc
risk
ci
compar
baselin
macrolid
resist
rate
major
longterm
studi
use
macrolid
antiinflammatori
antisecretagogu
effect
children
cf
children
idiopath
bronchiectasi
month
betacaroten
supplement
reduc
plasma
level
malondialdehyd
marker
lipid
peroxid
chang
clinic
statu
adult
bronchiectasi
nonsteroid
antiinflammatori
agent
major
effect
peripher
neutrophil
function
significantli
reduc
neutrophil
chemotaxi
fibronectin
degrad
rest
stimul
neutrophil
effect
bacteri
colon
airway
superoxid
anion
gener
neutrophil
studi
oral
nonsteroid
antiinflammatori
drug
nsaid
cochran
review
inhal
nsaid
found
singl
trial
csld
adult
bronchiectasi
tamaoki
et
al
report
signific
reduct
sputum
product
day
treatment
group
day
inhal
indomethacin
compar
placebo
signific
improv
dyspnea
score
signific
differ
group
lung
function
blood
indic
emerg
drug
develop
recent
review
mucoact
agent
enhanc
mucu
clearanc
respiratori
tract
condit
mucu
clearanc
impair
mucolyt
reduc
mucu
crosslink
viscos
disrupt
polym
network
secret
sever
disulfid
bond
depolymer
mucopolysaccharid
liquefi
protein
degrad
dna
filament
actin
adult
high
dose
bromhexin
avail
countri
use
antibiot
eas
difficulti
expector
reduc
sputum
product
recombin
deoxyribonucleas
rhdnase
efficaci
cf
contraind
noncf
bronchiectasi
doubleblind
rct
multicent
studi
adult
bronchiectasi
given
rhdnase
higher
exacerb
hospit
rate
rapid
pulmonari
declin
decreas
fev
rhdnase
group
placebo
group
inhal
osmot
agent
hyperton
salin
mannitol
improv
airway
clearanc
lung
function
reduc
exacerb
frequenc
peopl
cf
studi
adult
noncf
bronchiectasi
show
benefit
time
first
exacerb
qol
exacerb
rate
studi
children
clinic
select
children
commenc
hyperton
salin
use
pretreat
shortact
bronchodil
recommend
avoid
bronchospasm
occur
patient
antisecretagogu
reduc
airway
mucu
product
secret
agent
includ
anticholinerg
agent
macrolid
antibiot
bromhexin
fourteenmemb
macrolid
antibiot
antiinflammatori
activ
use
discuss
antimicrobi
section
rct
anticholinerg
treatment
acut
stabl
bronchiectasi
anticholinerg
agent
atropin
glycopyrrol
slow
mucociliari
transport
predispos
mucu
stasi
antimicrobi
treatment
key
intervent
manag
patient
bronchiectasi
stabl
adult
patient
direct
relationship
bacteri
load
risk
subsequ
sever
exacerb
or
ci
ci
respect
howev
publish
random
control
treatment
trial
childhood
bronchiectasi
none
focu
acut
exacerb
brief
antimicrobi
intervent
significantli
improv
inflammatori
profil
airway
blood
sputum
product
cough
frequenc
qol
measur
use
antimicrobi
bronchiectasi
recent
summar
gener
type
antimicrobi
target
known
pathogen
rout
depend
sever
ill
respons
previou
treatment
ideal
sputum
cultur
obtain
prior
initi
antibiot
oral
antibiot
usual
prescrib
initi
sever
episod
failur
improv
oral
agent
requir
intraven
antibiot
combin
intens
airway
clearanc
techniqu
although
robust
evid
lack
cours
antibiot
day
recommend
respiratori
specialist
comprehens
care
program
bronchiectasi
use
intermitt
antibiot
treat
exacerb
chronic
mainten
antibiot
treatment
strategi
use
mainten
antimicrobi
may
suitabl
select
situat
frequent
exacerb
like
occur
old
studi
adult
demonstr
regular
use
macrolid
trimethoprim
reduc
pulmonari
inflamm
infect
exacerb
improv
lung
function
pediatr
random
control
trial
rct
involv
children
week
roxithromycin
mgkg
twice
day
placebo
also
describ
signific
improv
sputum
marker
airway
respons
roxithromycin
group
improv
fev
observ
either
group
recent
studi
adult
children
confirm
find
howev
mani
question
remain
mainten
antibiot
start
optim
durat
studi
suggest
effect
evid
month
whether
macrolid
best
choic
mainten
treatment
macrolid
use
question
optim
type
dose
regimen
dailytoweekli
whether
associ
increas
aureu
macrolideresist
bacteria
harm
individu
commun
level
latest
cochran
review
children
adult
includ
consist
studi
wherebi
metaanalysi
show
patient
least
one
exacerb
use
mainten
antibiot
week
significantli
reduc
exacerb
compar
placebo
usual
care
reduct
exacerb
per
hospit
also
reduc
fewer
hospit
per
peopl
treat
threefold
higher
likelihood
antibiot
resist
group
use
mainten
antibiot
howev
sole
rct
report
use
antibiot
condit
respiratori
exacerb
antibiot
arm
requir
less
antibiot
incid
rate
ratio
ci
factor
affect
risk
develop
resist
longterm
macrolid
therapi
adher
utero
tobacco
smoke
exposur
alter
respiratori
control
pulmonari
develop
physiolog
tobacco
smoke
also
skew
earli
immun
function
role
perman
alter
local
system
pulmonari
immun
unknown
exposur
et
increas
suscept
respiratori
infect
caus
advers
respiratori
health
outcom
increas
cough
ill
cessat
parent
smoke
reduc
children
cough
behavior
counsel
motiv
interview
smoke
mother
reduc
young
children
et
exposur
report
object
measur
et
indoor
wood
smoke
also
increas
acut
respiratori
infect
demonstr
exposurerespons
effect
thu
effort
reduc
smoke
biomass
exposur
includ
utero
exposur
children
exposur
home
must
maxim
low
moder
qualiti
evid
repair
hous
decreas
respiratori
tract
infect
vaccin
per
nation
schedul
recommend
mani
diseas
describ
caus
bronchiectasi
eg
pertussi
measl
control
develop
countri
vaccin
prevent
influenza
recommend
despit
lack
evid
specif
bronchiectasi
specif
evid
influenza
vaccin
csldbronchiectasi
indirect
evid
suggest
annual
influenza
vaccin
reduc
morbid
mortal
health
care
cost
risk
group
pneumococc
vaccin
limit
evid
support
use
pneumococc
vaccin
reduc
acut
infect
exacerb
pneumococc
vaccin
recommend
highrisk
children
includ
bronchiectasi
current
evid
support
revaccin
although
frequenc
revaccin
controversi
recent
studi
found
vaccin
pneumococc
h
influenza
protein
conjug
vaccin
associ
improv
nthispecif
cellmedi
humor
immun
respons
children
csld
promis
confirmatori
data
requir
surgeri
consid
often
bronchiectasi
focal
medic
therapi
fail
surgeri
rare
undertaken
affluent
countri
still
common
intervent
less
affluent
countri
periop
mortal
lobectomi
pneumonectomi
fallen
dramat
retrospect
seri
children
mean
age
year
rang
minor
postop
complic
transient
atelectasi
air
leak
one
child
die
within
postop
period
children
averag
followup
period
day
show
improv
clinic
symptom
similar
sever
review
surgic
therapi
bronchiectasi
compil
group
adult
pediatr
patient
experienc
mortal
oper
complic
rate
complic
includ
empyema
bronchopulmonari
fistula
hypotens
bleed
surgic
treatment
bronchiectasi
effect
patient
local
diseas
appear
new
uncontrol
trial
tiotroprium
adult
hypersecretori
state
includ
bronchiectasi
resist
macrolid
reduc
daili
symptom
improv
qol
shortterm
use
current
recommend
children
although
lack
robust
evidencebas
airway
clearanc
techniqu
encompass
variou
type
chest
physiotherapi
recommend
children
adult
avail
studi
suggest
airway
clearanc
techniqu
benefici
improv
qol
exercis
capac
reduc
cough
sputum
volum
thu
daili
chest
physiotherapi
recommend
form
maxim
potenti
benefit
minim
burden
care
past
postur
drainag
standard
therapi
children
csldbronchiectasi
howev
treatment
may
increas
gastroesophag
reflux
possibl
aspir
given
avail
multipl
techniqu
airway
clearanc
lack
clear
superior
one
techniqu
specif
choic
individu
pediatricspecif
physiotherapist
expertis
sought
addit
children
bronchiectasi
encourag
particip
exercis
activ
asthma
children
bronchiectasi
treat
merit
inhal
corticosteroid
ic
best
modest
benefit
sever
csldbronchiectasi
p
aeruginosa
cochran
review
six
studi
adult
pediatr
studi
found
short
term
ic
month
durat
adult
high
dose
ic
g
per
day
budesonid
equival
significantli
improv
fev
fvc
qol
sputum
volum
improv
peak
flow
exacerb
cough
wheez
compar
adult
control
arm
ic
placebocontrol
studi
includ
review
signific
differ
group
outcom
examin
spirometri
clinic
outcom
exacerb
sputum
volum
singl
studi
mediumterm
month
outcom
show
signific
effect
inhal
steroid
outcom
publish
rct
use
ic
children
csldbronchiectasi
one
studi
report
withdraw
ic
result
signific
increas
bronchial
hyperreact
decreas
neutrophil
apoptosi
chang
children
clinic
paramet
sputum
inflammatori
marker
suggest
ic
littl
role
manag
csldbronchiectasi
children
asthma
coexist
shortand
longact
agonist
also
indetermin
role
manag
bronchiectasi
use
must
individu
although
presenc
asthma
associ
advanc
bronchiectasi
wors
prognosi
treatment
asthma
alter
longterm
outcom
studi
may
asthmat
featur
associ
diffus
bronchiectasi
reflect
diseas
rather
concurr
condit
whether
publish
guidelin
asthma
care
pertain
patient
wheez
airway
hyperact
unclear
increas
cough
children
bronchiectasi
initi
treat
exacerb
bronchiectasi
given
heterogen
etiolog
factor
host
respons
region
sever
distribut
bronchiectasi
surpris
prognosi
vari
rang
mild
respiratori
morbid
death
airway
obstruct
pulmonari
infect
respiratori
failur
hypercapnia
case
bronchiectasi
resolv
radiograph
treatment
howev
children
remain
risk
develop
bronchiectasi
monitor
regularli
reemerg
symptom
obstruct
lung
diseas
often
bronchiectasi
persist
hrct
becom
less
sever
clinic
fewer
infecti
exacerb
less
cough
evid
later
childhood
seri
children
hrctdocument
bronchiectasi
third
improv
third
remain
symptomat
stabl
third
worsen
receiv
medic
therapi
field
landau
et
al
report
reduct
exacerb
second
third
decad
life
despit
persist
bronchiectasi
radiograph
happen
follow
decad
infer
case
seri
adult
bronchiectasi
mani
onset
respiratori
problem
bronchiectasi
childhood
howev
seri
depict
era
minim
symptom
occur
adolesc
anecdot
reappear
age
year
old
three
publish
studi
retrospect
longitudin
fev
chang
children
noncf
bronchiectasi
studi
variabl
interv
vari
result
british
studi
n
year
n
year
found
lung
function
improv
intens
treatment
necessari
normal
likewis
australian
studi
n
year
n
year
found
lung
function
anthropometr
paramet
remain
stabl
followup
period
appropri
therapi
institut
low
function
diagnosi
fev
predict
improv
time
contrast
new
zealand
nz
studi
children
year
found
fev
declin
per
annum
explan
contrast
specul
like
includ
differ
age
group
children
differ
ethnic
health
care
differ
also
nz
cohort
extens
radiolog
diseas
bilater
diseas
median
four
diseas
lobe
multilobar
involv
brisban
studi
found
signific
predictor
fev
declin
year
frequenc
exacerb
requir
hospit
two
cohort
examin
determin
lung
function
declin
publish
data
also
suggest
delay
diagnosi
associ
poorer
outcom
larg
studi
adult
newli
diagnos
bronchiectasi
show
declin
fev
correl
durat
chronic
wet
cough
common
symptom
bronchiectasi
addit
year
product
cough
fev
predict
declin
nonsmok
adult
bronchiectasi
symptomat
childhood
much
poorer
lung
function
wors
chest
ct
scan
score
adultonset
symptom
brisban
longitudin
studi
children
diagnos
earlier
henc
manag
earlier
significantli
younger
better
longterm
spirometri
growth
paramet
fev
predict
decreas
bronchiectasi
follow
surgic
manag
describ
indic
surgic
intervent
controversi
data
appli
given
major
advanc
antibiot
airway
clearanc
techniqu
nutrit
supplement
socioeconom
standard
among
underserv
popul
suggest
indic
surgic
intervent
outlin
box
although
lung
transplant
report
wide
patient
cf
option
use
adult
endstag
noncf
bronchiectasi
outcom
follow
lung
transplant
children
without
cf
report
final
health
isol
social
econom
environment
educ
issu
health
health
behavior
close
link
socioeconom
factor
increas
poverti
associ
consequ
poor
hous
poor
water
suppli
independ
risk
factor
increas
respiratori
infect
associ
mortal
effect
reduc
morbid
mortal
csld
bronchiectasi
children
multifacet
approach
encompass
good
clinic
care
public
health
concern
bear
consider
although
beyond
scope
articl
address
import
issu
futur
work
must
focu
public
health
issu
predispos
childhood
bronchiectasi
dispar
develop
develop
countri
reduc
deliveri
chronic
diseas
program
requir
comprehens
highli
skill
cultur
compet
primari
health
care
educ
primari
health
provid
ideal
focu
identifi
children
appropri
referr
high
qualiti
local
manag
initi
assess
requir
specialist
expertis
specialist
evalu
recommend
confirm
diagnosi
investig
etiolog
assess
baselin
sever
develop
manag
plan
similar
chronic
ill
individu
multidisciplinari
case
manag
oper
within
interprofession
framework
optim
similarli
deterior
prompt
earli
referr
specialist
care
addit
moder
sever
diseas
best
manag
multidisciplinari
team
approach
chronic
cough
preval
rang
first
descript
pbb
bal
cultur
grew
common
respiratori
bacteri
pathogen
pneumonia
h
influenza
catarrhali
fig
subsequ
studi
confirm
find
although
one
retrospect
studi
also
identifi
aureu
children
upon
genotyp
belong
predominantli
adv
speci
c
presenc
role
biofilm
bal
children
pbb
studi
presenc
specul
microbiota
lung
children
pbb
examin
singl
crosssect
studi
oneway
analysi
varianc
show
shannonwein
index
measur
speci
divers
lower
airway
microbiota
children
pbb
bronchiectasi
similar
statist
higher
ie
richer
cf
lung
microbiota
children
significantli
differ
observ
adult
cf
bronchiectasi
suggest
chronic
airway
infect
begin
similarli
point
year
increas
age
diagnosi
statist
nonsignific
bronchiectasi
worsen
may
becom
increasingli
saccular
within
local
lung
region
see
fig
altern
bronchiectasi
extend
addit
airway
either
due
endobronchi
spread
infect
evolut
diseas
multipl
airway
site
frequenc
bronchiectasi
extend
new
lung
region
vari
differ
seri
local
progress
diseas
rather
extens
new
area
like
common
sever
case
bronchiectasi
diffus
airway
involv
accompani
airflow
limit
without
concomit
airway
hyperreact
diagnosi
asthma
context
underli
lung
diseas
may
difficult
wheez
asthma
symptom
common
peopl
csldbronchiectasi
although
report
preval
vari
studi
describ
asthma
caus
bronchiectasi
like
wheez
ill
secondari
coexist
condit
asthma
initi
misdiagnos
asthmalik
symptom
adult
bronchiectasi
may
associ
acceler
declin
lung
function
king
report
increas
use
bronchodil
led
trend
greater
fev
declin
time
adult
nz
cohort
found
presenc
asthma
associ
lower
fev
diagnosi
asthmat
slower
rate
declin
followup
unfavor
prognost
factor
patient
bronchiectasi
includ
presenc
asthma
bilater
lung
involv
saccular
bronchiectasi
frequenc
exacerb
presenc
p
aeruginosa
airway
advent
better
antibiot
inhal
antibiot
longterm
oxygen
therapi
improv
nutrit
improv
prognosi
cor
pulmonal
right
heart
failur
uncommon
complic
advanc
bronchiectasi
children
one
seri
echocardiographi
children
bronchiectasi
found
one
child
pulmonari
hypertens
addit
chronic
lung
infect
inflamm
independ
risk
factor
develop
cardiovascular
diseas
adult
prior
diagnosi
pbb
children
chronic
wet
cough
receiv
multipl
medic
consult
sever
health
physician
australian
multicent
studi
found
children
pbb
receiv
asthma
medic
seen
greater
five
doctor
previous
persist
cough
howev
find
also
similar
children
chronic
cough
caus
qol
score
children
pbb
similar
children
cough
due
asthma
bronchiectasi
present
pediatr
pulmonologist
importantli
qol
score
normal
cough
resolv
preval
pbb
case
commun
clinic
unknown
studi
specialist
clinic
pediatr
andor
pediatr
pulmonolog
australia
turkey
found
pbb
among
top
three
diagnos
children
bronchoscopi
respiratori
indic
tertiari
pediatr
hospit
vs
respect
howev
shown
prospect
studi
children
tbm
cf
control
higher
frequenc
respiratori
infect
symptom
children
pbb
chronic
wet
cough
otherwis
typic
appear
well
absenc
recurr
nasal
ear
diseas
normal
growth
develop
lack
sign
underli
csld
preval
atop
featur
eczema
system
airway
eosinophilia
elev
ige
posit
radioallergosorb
test
similar
children
without
pbb
mani
parent
report
previou
ever
wheez
wheez
auscult
confirm
doctor
unusu
occasion
rattli
chest
palpat
crackl
heard
chest
radiograph
normal
nearnorm
show
peribronchi
chang
perform
spirometri
respiratori
system
reactanc
resist
measur
fot
normal
pbb
first
describ
exist
distinct
diagnost
entiti
controversi
howev
becom
recogn
increasingli
incorpor
nation
pediatr
chronic
cough
guidelin
also
form
part
european
pediatr
respiratori
train
curriculum
pbb
first
defin
priori
base
clinic
experi
appli
subgroup
children
prospect
studi
evalu
etiolog
chronic
cough
diagnost
criteria
histori
chronic
wet
cough
posit
bal
cultur
respiratori
bacteri
pathogen
densiti
cfuml
without
serolog
pcr
assay
evid
infect
either
bordatella
pertussi
mycoplasma
pneumonia
cough
resolut
cours
oral
antibiot
amoxicillinclavulan
consider
feasibl
daytoday
clinic
practic
research
result
definit
box
base
recurr
clinic
set
criteria
valid
howev
uncertainti
remain
includ
diagnosi
determin
trial
therapi
lack
research
data
optim
length
antibiot
uncertainti
diagnost
threshold
determin
lower
airway
infect
differenti
acut
bronchiti
pbb
acut
bronchiti
cough
usual
resolv
within
week
difficulti
aris
recurr
acut
bronchiti
episod
overlap
especi
respiratori
viru
season
furthermor
pbb
coexist
ill
includ
asthma
recurr
episod
need
differenti
defect
airway
clearanc
otherwis
normal
airway
microbiota
time
antibiot
treatment
perhap
effect
underli
diseas
microbiota
diseas
group
progress
diverg
immun
inflamm
studi
immun
children
pbb
report
follow
featur
absenc
overt
system
immunodefici
normal
serum
iga
igm
igg
ige
level
robust
respons
protein
tetanu
conjug
proteinpolysaccharid
h
influenza
type
b
vaccin
bal
children
pbb
typic
show
intens
airway
neutrophilia
median
whether
patholog
disproportion
respons
infect
unknown
also
mark
proinflammatori
mediat
respons
increas
correl
bal
neutrophil
percentag
median
bal
level
children
pbb
higher
control
children
whose
cough
resolv
without
treatment
children
pbb
significantli
higher
bal
fluid
level
pathway
member
gene
protein
express
nonpbb
diseas
control
level
correl
durat
sever
cough
elev
express
pbb
case
recurr
pbb
next
month
gene
express
signal
molecul
receptor
associ
kinas
irak
bal
initi
bronchoscopi
significantli
higher
without
recurr
pbb
suggest
pathway
involv
recurr
thu
pbb
character
increas
pathway
activ
relat
mediat
associ
bal
neutrophil
cough
symptom
diseas
recurr
provid
insight
pbb
pathogenesi
larg
airway
lesion
clinician
believ
tbm
caus
chronic
ineffect
cough
like
airway
malacia
predispos
individu
prolong
ineffici
airway
clearanc
henc
increas
risk
infect
sinc
cough
resolv
underli
infect
treat
suggest
malacia
limit
caus
role
nevertheless
tbm
found
commonli
children
pbb
associ
may
primari
airway
malacia
predispos
pbb
reduc
effici
airway
clearanc
secondari
malacia
develop
intens
airway
inflamm
infect
one
retrospect
studi
report
tbm
present
children
pbb
howev
prospect
studi
involv
children
pbb
found
airway
abnorm
common
children
pbb
undergo
receiv
diagnosi
adjust
ci
mani
caus
chronic
wet
cough
children
investig
elucid
caus
necessari
child
respond
antibiot
andor
clinic
featur
exampl
cough
feed
address
elsewher
textbook
bronchiti
compon
mani
airway
diseas
liter
translat
word
bronchiti
refer
inflamm
bronchu
bronchi
howev
bronchiti
differ
major
overlap
construct
base
durat
acut
subacut
chronic
inflamm
type
neutrophil
eosinophil
lymphocyt
neurogen
phenotyp
clinic
syndrom
eg
acut
bronchiti
larygnotracheobronch
pbb
aspir
bronchiti
diagnost
entiti
may
vari
type
airway
inflamm
tabl
exampl
acut
viral
bronchiti
associ
lymphocyt
neutrophil
inflamm
although
type
airway
inflamm
distinguish
etiolog
bronchiti
children
provid
support
diagnosi
cough
usual
occur
bronchiti
present
chronic
week
wet
cough
children
signifi
persist
increas
airway
secret
product
decreas
airway
clearanc
larg
airway
greater
amount
secret
seen
bronchoscopi
higher
likelihood
bacteri
infect
intens
neutrophilia
airway
clinician
need
cogniz
recognit
wet
cough
depend
clinic
set
also
like
age
depend
easier
detect
wet
cough
young
children
older
children
may
product
cough
may
dri
cough
ask
cough
parent
clinician
vari
abil
recogn
cough
qualiti
australia
brisbanebas
parent
accur
determin
type
cough
compar
pulmonologist
kappa
ci
elev
neutrophil
elastas
cystic
fibrosi
elev
neutrophil
elastas
proteas
protract
bacteri
bronchiti
elev
relat
mediat
reflect
pathway
activ
chronic
lung
diseas
prematur
proinflammatori
cytokin
chemokin
sever
bronchiol
myeloperoxidas
rsv
protein
mrna
transcript
sever
rsv
bronchiol
bronchiol
obliteran
elev
aspir
lung
diseas
index
lipidladen
macrophag
nonspecif
marker
amylas
pepsin
still
need
valid
eosinophil
atop
asthma
elev
nitric
oxid
steroid
naiv
helminth
infect
eg
toxocara
strongyloid
allerg
bronchopulmonari
aspergillosi
neutrophil
inflamm
may
also
present
elev
hypersensit
eosinophil
pneumonia
lymphocyt
acut
viral
infect
solubl
intercellular
adhes
bronchiol
obliteran
lymphocyt
autoimmun
diseas
neurogen
post
rsv
infect
substanc
p
nerv
growth
factor
cough
gastroesophag
reflux
calcitonin
grelat
peptid
specif
cough
pointer
chest
pain
histori
suggest
inhal
foreign
bodi
dyspnea
exert
dyspnea
hemoptysi
failur
thrive
feed
difficulti
includ
chokingvomit
cardiac
neurodevelopment
abnorm
recurr
sinopulmonari
infect
immunodefici
epidemiolog
risk
factor
exposur
tuberculosi
sign
respiratori
distress
digit
club
chest
wall
deform
auscultatori
crackl
chest
radiograph
chang
perihilar
chang
lung
function
abnorm
bronchiectasi
chronic
wet
cough
respond
greater
week
oral
antibiot
among
children
persist
cough
despit
least
week
antibiot
bronchiectasi
children
whose
cough
resolv
antibiot
six
control
vs
respect
cohort
p
parentreport
wheez
preced
month
vs
p
end
studi
pbb
experienc
recurr
episod
per
year
bronchiectasi
diagnos
chest
ct
scan
major
independ
risk
factor
bronchiectasi
h
influenza
mainli
nthi
lower
airway
infect
sibl
h
influenza
infect
confer
greater
six
time
higher
risk
bronchiectasi
h
influenza
neg
state
hazard
ratio
ci
highqual
evid
children
greater
week
durat
wet
product
cough
use
appropri
antibiot
improv
cough
resolut
pbb
child
cough
resolv
cours
appropri
antibiot
contrast
shorter
durat
treatment
metaanalys
three
rct
use
day
antibiot
chronic
wet
cough
found
number
need
treat
benefit
end
studi
ci
although
british
thorac
societi
bt
cough
guidelin
suggest
children
pbb
receiv
week
antibiot
prospect
deriv
evid
children
pbb
may
need
longer
antibiot
treatment
advoc
shorter
cours
initi
rate
risk
factor
pbb
recurr
like
depend
sampl
frame
definit
factor
sever
enough
need
bronchoscopi
bal
sampl
probabl
differ
enrol
commun
sole
prospect
studi
date
undertaken
children
pbb
follow
median
month
iqr
median
age
bronchoscopi
month
iqr
followup
children
pbb
like
cough
compar
